Antiviral potential of interferon omega on hepatitis B virus replication in human hepatoma cells
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1998
|
| In: |
Arzneimittel-Forschung
Year: 1998, Jahrgang: 48, Pages: 343-347 |
| ISSN: | 0004-4172 |
| Online-Zugang: |
|
| Verfasserangaben: | Jens Hagelstein, Peter R. Galle |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1918912920 | ||
| 003 | DE-627 | ||
| 005 | 20250716234931.0 | ||
| 007 | tu | ||
| 008 | 250303s1998 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)1918912920 | ||
| 035 | |a (DE-599)KXP1918912920 | ||
| 035 | |a (OCoLC)1528019964 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hagelstein, Jens |e VerfasserIn |0 (DE-588)1342436644 |0 (DE-627)1902984358 |4 aut | |
| 245 | 1 | 0 | |a Antiviral potential of interferon omega on hepatitis B virus replication in human hepatoma cells |c Jens Hagelstein, Peter R. Galle |
| 264 | 1 | |c 1998 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Galle, Peter R. |d 1957- |e VerfasserIn |0 (DE-588)1111061963 |0 (DE-627)865474168 |0 (DE-576)475908953 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Arzneimittel-Forschung |d Stuttgart : Thieme, 1951 |g 48(1998), Seite 343-347 |w (DE-627)130101516 |w (DE-600)502081-5 |w (DE-576)015634078 |x 0004-4172 |7 nnas |a Antiviral potential of interferon omega on hepatitis B virus replication in human hepatoma cells |
| 773 | 1 | 8 | |g volume:48 |g year:1998 |g pages:343-347 |g extent:5 |a Antiviral potential of interferon omega on hepatitis B virus replication in human hepatoma cells |
| 951 | |a AR | ||
| 992 | |a 20250303 | ||
| 993 | |a Article | ||
| 994 | |a 1998 | ||
| 998 | |g 1111061963 |a Galle, Peter R. |m 1111061963:Galle, Peter R. |d 910000 |d 910100 |e 910000PG1111061963 |e 910100PG1111061963 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 1342436644 |a Hagelstein, Jens |m 1342436644:Hagelstein, Jens |d 50000 |e 50000PH1342436644 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1918912920 |e 4680628073 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Jens","family":"Hagelstein","role":"aut","display":"Hagelstein, Jens","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Galle, Peter R.","given":"Peter R.","family":"Galle"}],"name":{"displayForm":["Jens Hagelstein, Peter R. Galle"]},"title":[{"title_sort":"Antiviral potential of interferon omega on hepatitis B virus replication in human hepatoma cells","title":"Antiviral potential of interferon omega on hepatitis B virus replication in human hepatoma cells"}],"origin":[{"dateIssuedDisp":"1998","dateIssuedKey":"1998"}],"id":{"eki":["1918912920"]},"type":{"bibl":"article-journal"},"physDesc":[{"extent":"5 S."}],"recId":"1918912920","language":["eng"],"relHost":[{"name":{"displayForm":["Red. Hans-Georg Classen ; Viktor Schramm"]},"id":{"eki":["130101516"],"zdb":["502081-5"],"issn":["0004-4172"]},"origin":[{"publisherPlace":"Stuttgart ; New York, NY ; Aulendorf","dateIssuedKey":"1951","publisher":"Thieme ; Editio-Cantor-Verl.","dateIssuedDisp":"1951-2012"}],"physDesc":[{"noteFormat":"28 cm"}],"title":[{"subtitle":" = Drug research","title":"Arzneimittel-Forschung","title_sort":"Arzneimittel-Forschung"}],"recId":"130101516","language":["ger","eng"],"note":["Ungezählte Beil.: Special section Biotechnology in drug research"],"disp":"Antiviral potential of interferon omega on hepatitis B virus replication in human hepatoma cellsArzneimittel-Forschung","type":{"bibl":"periodical"},"titleAlt":[{"title":"Biotechnology in drug research"},{"title":"Publikationsorgan der Paul-Ehrlich-Gesellschaft für Chemotherapie"},{"title":"Veröffentlichungen über Forschungs- und Prüfungsergebnisse insbesondere neu zu entwickelnder Arzneistoffe einschließlich neuer wissenschaftlicher Erkenntnisse von bereits auf dem Markt sich befindenden Präparaten"}],"part":{"pages":"343-347","year":"1998","extent":"5","volume":"48","text":"48(1998), Seite 343-347"},"pubHistory":["1.1951,Apr. - 62.2012"],"titleTranslated":[{"translated":"Drug research"}]}]} | ||
| SRT | |a HAGELSTEINANTIVIRALP1998 | ||